NJK14047
CAS No. 1800576-41-3
NJK14047( NJK 14047 )
Catalog No. M12739 CAS No. 1800576-41-3
NJK14047 is a novel potent, selective p38 MAPK inhibitor with IC50 of 27 nM against p38α.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNJK14047
-
NoteResearch use only, not for human use.
-
Brief DescriptionNJK14047 is a novel potent, selective p38 MAPK inhibitor with IC50 of 27 nM against p38α.
-
DescriptionNJK14047 is a novel potent, selective p38 MAPK inhibitor with IC50 of 27 nM against p38α, suppresses RSV and influenza A virus replication by inhibiting virus-induced p38 MAPK activation; inhibits RSV- and influenza A-mediated p38 MAPK activation in epithelial cells, decreases viral replication and viral mRNA synthesis; also displays significant anti-HBV activity, efficiently suppresses the secretion of HBV antigens and HBV particles from HBV genome-transfected cells.
-
In Vitro——
-
In Vivo——
-
SynonymsNJK 14047
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptorp38 MAPK
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number1800576-41-3
-
Formula Weight445.515
-
Molecular FormulaC27H27NO5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=C(C=C(C=C1)C(=O)NC2CC2)C3=CC=C(C=C3)C(=O)C4=CC=C(C=C4)OCC(CO)O
-
Chemical NameN-cyclopropyl-4'-(4-(2,3-dihydroxypropoxy)benzoyl)-6-methyl-[1,1'-biphenyl]-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kim SY, et al. Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00214-17.
2. Choi MS, et al. Biochem Biophys Res Commun. 2016 Aug 26;477(3):311-6.
3. Heo J, et al. Bioorg Med Chem Lett. 2015 Sep 1;25(17):3694-8.
molnova catalog
related products
-
PAF (C16)
PAF (C16) is a potent MAPK and MEK/ERK activator that induces increased vascular permeability. PAF (C16) (PAF (C16)) is a platelet-activating factor, a phospholipid-derived mediator and a ligand for PAF G protein-coupled receptor (PAFR). PAF (C16) has shown anti-apoptotic and anti-inflammatory activity in vitro, inhibiting Caspase-dependent apoptosis by interacting with its receptor (PAF-R) to perform cell signaling.
-
p38α inhibitor 1
p38α inhibitor 1 is an inhibitor of p38α .
-
APS6-45
APS6-45 inhibits RAS/MAPK signaling and exhibits anti-tumor activity.
Cart
sales@molnova.com